US 9404114
Antisense modulation of GCGR expression
granted A61KA61K31/711A61P
Quick answer
US patent 9404114 (Antisense modulation of GCGR expression) held by Ionis Pharmaceuticals, Inc. expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/711, A61P, A61P3/00, A61P3/08